SHERI MILLER: Open Payments
NPI 1427413228 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 52 payments from 14 companies in 2025. Trend: 2023 $764 · 2024 $1,216 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $215 |
| Regeneron Healthcare Solutions, Inc. | 4 | $134 |
| Phathom Pharmaceuticals, Inc. | 8 | $120 |
| Madrigal Pharmaceuticals | 6 | $108 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $92 |
| Janssen Biotech, Inc. | 4 | $70 |
| GENZYME CORPORATION | 2 | $58 |
| Novo Nordisk Inc | 2 | $43 |
| Ardelyx, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $39 |
Products named: ENTYVIO, DUPIXENT, VOQUEZNA, REZDIFFRA, XIFAXAN, TREMFYA, Wegovy, IBSRELA.
Industry payments across OH — which companies pay providers there.
